ADIPOR1 and colorectal carcinoma: An evaluation of ADIPOQ’s receptor PBMC expression levels showed that ADIPOR1 mRNA levels were decreased in CRC, while ADIPOR2 mRNA levels did not differ between the groups (Table 1).